EPISODE · Jul 15, 2026 · 45 MIN
Weave’s Brandon Rice on Rebuilding Drug Regulation with AI
from NEJM AI Grand Rounds · host NEJM Group
Brandon Rice believes that improving health care sometimes means improving the systems behind it. Through his work at Weave, he focuses on modernizing the regulatory infrastructure that helps bring new medicines to market. He discusses the challenge of organizing scientific knowledge, communicating with regulators, and navigating processes that can span more than a decade. His vision is that AI can reduce administrative burden while preserving the rigor required for patient safety and scientific progress. Transcript.
Embed this episode
NOW PLAYING
Weave’s Brandon Rice on Rebuilding Drug Regulation with AI
No transcript for this episode yet
Similar Episodes
No similar episodes found.